Literature DB >> 27757150

An Endocrine Cause of Acute Post-partum Hypertension.

Ingrid Bretherton1, David Pattison1, Sarah Pattison1, Suresh Varadarajan2.   

Abstract

This is a case of acute peri-partum hypertension secondary to Conn's syndrome. The timing of presentation offers a rare insight into the hormonal physiology of pregnancy and its impact on blood pressure regulation. This case highlights the challenges of diagnosing primary hyperaldosteronism in the peripartum period and the high index of suspicion required by the obstetric physician.

Entities:  

Keywords:  complications; endocrinology; general medicine; hypertension; physiology

Year:  2013        PMID: 27757150      PMCID: PMC5052777          DOI: 10.1258/OM.2012.120012

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  16 in total

1.  Primary aldosteronism as a cause of severe postpartum hypertension in two women.

Authors:  M Nezu; Y Miura; T Noshiro; M Inoue
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

Review 2.  Primary aldosteronism in pregnancy.

Authors:  J Matsumoto; H Miyake; T Isozaki; T Koshino; T Araki
Journal:  J Nippon Med Sch       Date:  2000-08       Impact factor: 0.920

3.  Postpartum hypertension and nonsteroidal analgesia.

Authors:  Angela Makris; Charlene Thornton; Annemarie Hennessy
Journal:  Am J Obstet Gynecol       Date:  2004-02       Impact factor: 8.661

4.  Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman.

Authors:  Kazuto Shigematsu; Noriyuki Nishida; Hideki Sakai; Tsukasa Igawa; Shin Suzuki; Kioko Kawai; Osamu Takahara
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

5.  Laparoscopic treatment of primary hyperaldosteronism in a pregnant patient.

Authors:  Tarik Zafer Nursal; Kenan Caliskan; Eda Ertorer; Ayse Parlakgumus; Gokhan Moray
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

6.  Saluretic action of aldosterone in the presence of excess cortisol: restoration of salt-retaining action by prolactin.

Authors:  D F Horrobin; M S Manku; P G Burstyn
Journal:  J Endocrinol       Date:  1973-02       Impact factor: 4.286

7.  Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy.

Authors:  M Wilson; A A Morganti; I Zervoudakis; R L Letcher; B M Romney; P Von Oeyon; S Papera; J E Sealey; J H Laragh
Journal:  Am J Med       Date:  1980-01       Impact factor: 4.965

8.  Pregnancy and primary aldosteronism.

Authors:  E G Biglieri; P E Slaton
Journal:  J Clin Endocrinol Metab       Date:  1967-11       Impact factor: 5.958

9.  Laparoscopic adrenalectomy for primary hyperaldosteronism during pregnancy.

Authors:  A L Shalhav; J Landman; J Afane; R Levi; R V Clayman
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2000-06       Impact factor: 1.878

10.  Primary aldosteronism aggravated during peripartum period.

Authors:  W Aoi; Y Doi; S Tasaki; T Mitsuoka; S Suzuki; K Hashiba
Journal:  Jpn Heart J       Date:  1978-11
View more
  4 in total

1.  Primary hyperaldosteronism presenting as persistent postpartum hypertension: Illustrative case and systematic review.

Authors:  Caitlin Kilmartin; Touhid Opu; Tiina Podymow; Natalie Dayan
Journal:  Obstet Med       Date:  2018-05-22

Review 2.  Primary aldosteronism in pregnancy.

Authors:  Vittorio Forestiero; Elisa Sconfienza; Paolo Mulatero; Silvia Monticone
Journal:  Rev Endocr Metab Disord       Date:  2022-05-10       Impact factor: 9.306

Review 3.  Primary Aldosteronism Presenting with Hypertension Five Days after Delivery: A Case Report and Literature Review.

Authors:  Nobumasa Ohara; Michi Kobayashi; Yuichiro Yoneoka; Go Hasegawa; Yayoi Aoki; Yasuhiro Nakamura; Yoshiki Kazama; Tsutomu Nishiyama
Journal:  Intern Med       Date:  2021-08-13       Impact factor: 1.271

4.  Functioning Endocrine Tumors in Pregnancy: Diagnostic and Therapeutic Challenges.

Authors:  Kripa E Cherian; Nitin Kapoor; Thomas V Paul; Hesarghatta S Asha
Journal:  Indian J Endocrinol Metab       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.